Analysen von Michael Leuchten
| 06.12.17 | Novo Nordisk buy | UBS AG | |
| 28.11.17 | Novo Nordisk buy | UBS AG | |
| 27.11.17 | GSK buy | UBS AG | |
| 09.11.17 | Merck buy | UBS AG | |
| 03.11.17 | Bayer buy | UBS AG | |
| 01.11.17 | Novo Nordisk buy | UBS AG | |
| 30.10.17 | Novartis Neutral | UBS AG | |
| 27.10.17 | Bayer buy | UBS AG | |
|
Werbung
|
|||
| 26.10.17 | GSK Neutral | UBS AG | |
| 17.10.17 | Novo Nordisk buy | UBS AG | |
| 10.10.17 | GSK Neutral | UBS AG | |
| 29.09.17 | Merck buy | UBS AG | |
| 26.09.17 | Merck buy | UBS AG | |
| 13.09.17 | Bayer buy | UBS AG | |
| 28.08.17 | Novartis Neutral | UBS AG | |
| 24.08.17 | Bayer buy | UBS AG | |
| 23.08.17 | Bayer buy | UBS AG | |
| 17.08.17 | Novo Nordisk buy | UBS AG | |
| 10.08.17 | Novo Nordisk buy | UBS AG | |
| 01.08.17 | Novo Nordisk buy | UBS AG | |
| 01.08.17 | GSK Neutral | UBS AG | |
| 27.07.17 | GSK Neutral | UBS AG | |
| 27.07.17 | Bayer buy | UBS AG | |
| 26.07.17 | GSK Neutral | UBS AG | |
| 26.07.17 | Novo Nordisk buy | UBS AG | |
| 20.07.17 | Novartis Neutral | UBS AG | |
| 18.07.17 | Novartis Neutral | UBS AG | |
| 04.07.17 | Bayer buy | UBS AG | |
| 03.07.17 | Bayer buy | UBS AG | |
| 27.06.17 | Bayer buy | UBS AG | |
| 12.06.17 | Novo Nordisk buy | UBS AG | |
| 09.06.17 | GSK Neutral | UBS AG | |
| 07.06.17 | Bayer buy | UBS AG | |
| 24.05.17 | Novartis Neutral | UBS AG | |
| 15.05.17 | GSK Neutral | UBS AG | |
| 12.05.17 | Bayer buy | UBS AG | |
| 04.05.17 | Novo Nordisk buy | UBS AG | |
| 03.05.17 | Novo Nordisk buy | UBS AG | |
| 28.04.17 | Novo Nordisk buy | UBS AG | |
| 27.04.17 | GSK Neutral | UBS AG | |
| 21.04.17 | Novartis Neutral | UBS AG | |
| 06.04.17 | Novartis Neutral | UBS AG | |
| 14.03.17 | Novartis Neutral | UBS AG | |
| 09.03.17 | Novo Nordisk buy | UBS AG | |
| 08.03.17 | GSK Neutral | UBS AG | |
| 16.02.17 | Novo Nordisk buy | UBS AG | |
| 14.02.17 | GSK Neutral | UBS AG | |
| 03.02.17 | Novo Nordisk buy | UBS AG | |
| 19.01.17 | Novo Nordisk buy | UBS AG | |
| 15.12.16 | Bayer buy | UBS AG | |